Caribou Biosciences Inc

Stock Chart, Company Information, and Scan Results

$2.13(as of Apr 27, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Caribou Biosciences Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.13
Ticker SymbolCRBU
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees97
CountyUSA
Market Cap$205.8M
EBIDTA-130.3M
10-Day Moving Average2.21
P/E Ratio-1.36
20-Day Moving Average2.06
Forward P/E Ratio0.00
50-Day Moving Average1.94
Earnings per Share-1.59
200-Day Moving Average1.93
Profit Margin-672.11%
RSI54.06
Shares Outstanding96.6M
ATR0.13
52-Week High3.54
Volume2,138,667
52-Week Low0.73
Most Recent Support Level2.10
Book Value122.2M
Most Recent Resistance Level2.22
P/B Ratio1.65
Upper Keltner2.36
P/S Ratio18.04
Lower Keltner1.76
Debt-to-Equity Ratio2.36
Next Earnings Date05/12/2026
Cash Surplus-13.1M
Next Ex-Dividend DateUnknown

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Caribou Biosciences Inc In Our Stock Scanner

As of Apr 28, 2026
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.